Recent studies have reported that eIF5A2 is aberrantly expressed in several types of tumor cells, including rectal carcinoma, gastric cancer, ovarian cancer, bladder cancer, and colon cancer [18, 23–25]. This evidence concerns the gene EIF5A2 and malignant colon neoplasm.